Loading...
Loading...
India's pembrolizumab imports from AUSTRIA total $3.4K across 1 shipments from 1 foreign suppliers. SIA GP NORD leads with $3.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CADILA HEALTHCARE LIMITED. This corridor reflects India's pharmaceutical import demand for pembrolizumab โ a concentrated sourcing relationship with select suppliers from AUSTRIA.

SIA GP NORD is the leading Pembrolizumab supplier from AUSTRIA to India, with import value of $3.4K across 1 shipments. The top 5 suppliers โ SIA GP NORD โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SIA GP NORD | $3.4K | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CADILA HEALTHCARE LIMITED | $3.4K | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Pembrolizumab suppliers from AUSTRIA to India include SIA GP NORD. The leading supplier is SIA GP NORD with import value of $3.4K USD across 1 shipments. India imported Pembrolizumab worth $3.4K USD from AUSTRIA in total across 1 shipments.
India imported Pembrolizumab worth $3.4K USD from AUSTRIA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Pembrolizumab sourced from AUSTRIA include CADILA HEALTHCARE LIMITED. The largest buyer is CADILA HEALTHCARE LIMITED with $3.4K in imports across 1 shipments.
The total value of Pembrolizumab imports from AUSTRIA to India is $3.4K USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists